Arthritis drugs ‘improve survival and recovery’ of Covid-19 patients

Drugs typically used for rheumatoid arthritis are to be rolled out to Covid-19 patients in intensive care, after new research showed their effectiveness in reducing mortality and length of hospital stay. The findings, which have not yet been peer-reviewed, come from the government-funded REMAP-CAP clinical…

The post Arthritis drugs ‘improve survival and recovery’ of Covid-19 patients appeared first on Nursing Times.



0 comments:

Post a comment